CAMBRIDGE, Mass., Nov. 15, 2021 /PRNewswire/ -- Akebia
Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company
with the purpose to better the lives of people impacted by kidney
disease, today announced that John P.
Butler, Chief Executive Officer, will present at the
Jefferies London Healthcare Conference, which takes place
November 16 – 19, 2021.
The on-demand presentation will be available beginning at
8:00 a.m. GMT on November 18 through the conference site. The
webcast will also be available through the Investors section of the
Company's website at https://ir.akebia.com for approximately
30 days following the conference.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is
a fully integrated biopharmaceutical company with the purpose to
better the lives of people impacted by kidney disease. The Company
was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
Mcarrasco@akebia.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-jefferies-london-healthcare-conference-301423656.html
SOURCE Akebia Therapeutics